Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1980 May;99(2):463–474.

The effects of neonatal androgenization on mammary gland mitotic rate and susceptibility of carcinogen-induced mammary dysplastigenesis and tumorigenesis in LEW/Mai rats.

D M Purnell
PMCID: PMC1903501  PMID: 6769336

Abstract

The influence of neonatal testosterone propionate treatment (androgenization) on mammary gland mitotic rate (MR) and susceptibility to 7,12-dimethylbenz(alpha)anthracene (DMBA) carcinogenesis was studied in female LEW/Mai rats. Mammary gland MR in androgenized rats was significantly lower than MR in normal rats at all ages studied. Treatment of androgenized rats with DMBA resulted in a significant increase in mammary gland MR in comparison with untreated androgenized rats. MR in DMBA-treated androgenized rats was similar to MR in DMBA-treated normal rats at most intervals after the introduction of the carcinogen. Although mammary epithelial MR in androgenized rats was significantly lower than that of normal rats of comparable age, no evidence of a decrease in susceptibility of mammary epithelium in androgenized rats to DMBA carcinogenesis was found. Instead, androgenized rats had a higher incidence of DMBA-induced mammary dysplasias, with no change in their morphologic or histologic features, than did normal rats; and there was no change in the incidence, latency, or histopathologic appearance of DMBA-induced mammary tumors in androgenized versus normal rats.

Full text

PDF
463

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bern H. A., Jones L. A., Mori T., Young P. N. Exposure of neonatal mice to steroids: longterm effects on the mammary gland and other reproductive structures. J Steroid Biochem. 1975 May;6(5):673–676. doi: 10.1016/0022-4731(75)90051-5. [DOI] [PubMed] [Google Scholar]
  2. Christakos S., Sinha D., Dao T. L. Neonatal modification of endocrine functions and mammary carcinogenesis in the rat. Br J Cancer. 1976 Jul;34(1):58–63. doi: 10.1038/bjc.1976.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Jones L. A., Bern H. A. Long-term effects of neonatal treatment with progesterone, alone and in combination with estrogen, on the mammary gland and reproductive tract of female BALB/cfC3H mice. Cancer Res. 1977 Jan;37(1):67–75. [PubMed] [Google Scholar]
  4. Kovács K. Effect of androgenisation on the development of mammary tumours in rats induced by the oral administration of 9,10-dimethyl-1,2-benzanthracene. Br J Cancer. 1965 Sep;19(3):531–537. doi: 10.1038/bjc.1965.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Mallampati R. S., Johnson D. C. Serum and pituitary prolactin, LH, and FSH in androgenized female and normal male rats treated with various doses of estradiol benzoate. Neuroendocrinology. 1973;11(1):46–56. doi: 10.1159/000122117. [DOI] [PubMed] [Google Scholar]
  6. Mori T., Bern H. A., Mills K. T., Young P. N. Long-term effects of neonatal steroid exposure on mammary gland development and tumorigenesis in mice. J Natl Cancer Inst. 1976 Nov;57(5):1057–1062. doi: 10.1093/jnci/57.5.1057. [DOI] [PubMed] [Google Scholar]
  7. Nagasawa H., Mori T., Yanai R., Bern H. A., Mills K. T. Long-term effects of neonatal hormonal treatments on plasma prolactin levels in female BALB/cfC3H and BALB/c mice. Cancer Res. 1978 Apr;38(4):942–945. [PubMed] [Google Scholar]
  8. Nagasawa H., Yanai R. Frequency of mammary cell division in relation to age: its significance in the induction of mammary tumors by carcinogen in rats. J Natl Cancer Inst. 1974 Feb;52(2):609–610. doi: 10.1093/jnci/52.2.609. [DOI] [PubMed] [Google Scholar]
  9. Nagasawa H., Yanai R., Shodono M., Nakamura T., Tanabe Y. Effect of neonatally administered estrogen or prolactin on normal and neoplastic mammary growth and serum estradiol-17 beta level in rats. Cancer Res. 1974 Oct;34(10):2643–2646. [PubMed] [Google Scholar]
  10. Nagasawa H., Yanai R., Taniguchi H. Importance of mammary gland DNA synthesis on carcinogen-induced mammary tumorigenesis in rats. Cancer Res. 1976 Jul;36(7 Pt 1):2223–2226. [PubMed] [Google Scholar]
  11. Purnell D. M., Stowers D. J. Mammary gland hyperplastic alveolar noduligenesis in the LEW/Mai rat in relation to mitotic activity, estrous cycle status, and age. J Natl Cancer Inst. 1978 Nov;61(5):1339–1346. doi: 10.1093/jnci/61.5.1339. [DOI] [PubMed] [Google Scholar]
  12. Purnell D. M. The relationship of terminal duct hyperplasia to mammary carcinoma in 7,12-dimethylbenz(alpha)anthracene-treated LEW/Mai rats. Am J Pathol. 1980 Feb;98(2):311–324. [PMC free article] [PubMed] [Google Scholar]
  13. Shellabarger C. J., Soo V. A. Effects of neonatally administered sex steroids on 7,12-dimethylbenz(a)anthracene-induced mammary neoplasia in rats. Cancer Res. 1973 Jul;33(7):1567–1569. [PubMed] [Google Scholar]
  14. TAKEWAKI K. Some aspects of hormonal mechanism involved in persistent estrus in the rat. Experientia. 1962 Jan 15;18:1–6. doi: 10.1007/BF02136625. [DOI] [PubMed] [Google Scholar]
  15. Warner M. R., Warner R. L. Effects of exposure of neonatal mice to 17beta-estradiol on subsequent age-incidence and morphology of carcinogen-induced mammary dysplasia. J Natl Cancer Inst. 1975 Aug;55(2):289–298. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES